Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Vaxart Inc | VXRT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00155 | 0.24% | 0.65255 | 0.6757 | 0.64 | 0.6456 | 0.651 | 11:21:10 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.6451 | 0.66 | 0.0149 | 2.26% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 179 | 42,510 | $ 0.6636458 | $ 28,212 | 294,519 | 0.5223 - 7.60 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:22:15 | 8 | $ 0.6525 | USD |
Vaxart Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 10.30M | 15.79M | $ -18.01M | -2.34 | - | 13.22M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 10.00 | 16.30% |
Vaxart News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VXRT Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.681 | 0.7798 | 0.6012 | 0.6869 | 749k | -0.02845 | -4.18% |
| 1 Month | 0.65 | 0.7798 | 0.6012 | 0.6907 | 315k | 0.00255 | 0.39% |
| 3 Months | 0.7322 | 0.922 | 0.55 | 0.6875 | 199k | -0.07965 | -10.88% |
| 6 Months | 1.61 | 5 | 0.5223 | 1.5165 | 636k | -0.95745 | -59.47% |
| 1 Year | 2.81 | 7.6 | 0.5223 | 2.3052 | 442k | -2.15745 | -76.78% |
| 3 Years | 15.62 | 22 | 0.5223 | 4.9683 | 313k | -14.96745 | -95.82% |
| 5 Years | 24.86 | 33 | 0.5223 | 7.5781 | 216k | -24.20745 | -97.38% |
Vaxart Description
| Vaxart Inc is a biopharmaceutical company. It is focused on the discovery and development of direct-acting antivirals to treat infections that affect patients globally. The company has three product candidates which are; vapendavir, an oral treatment for human rhinovirus (HRV) upper respiratory infections in moderate-to-severe asthmatics; BTA585, an oral fusion protein inhibitor for the treatment and prevention of respiratory syncytial virus (RSV) infections, and BTA074, a topical antiviral treatment in for condyloma caused by human papillomavirus. |
